1037 related articles for article (PubMed ID: 28411163)
1. Development of a multi-epitope peptide vaccine inducing robust T cell responses against brucellosis using immunoinformatics based approaches.
Saadi M; Karkhah A; Nouri HR
Infect Genet Evol; 2017 Jul; 51():227-234. PubMed ID: 28411163
[TBL] [Abstract][Full Text] [Related]
2. Immuno-informatics based approaches to design a novel multi epitope-based vaccine for immune response reinforcement against Leptospirosis.
Validi M; Karkhah A; Prajapati VK; Nouri HR
Mol Immunol; 2018 Dec; 104():128-138. PubMed ID: 30448609
[TBL] [Abstract][Full Text] [Related]
3. Identification of potential antigens from non-classically secreted proteins and designing novel multitope peptide vaccine candidate against Brucella melitensis through reverse vaccinology and immunoinformatics approach.
Vishnu US; Sankarasubramanian J; Gunasekaran P; Rajendhran J
Infect Genet Evol; 2017 Nov; 55():151-158. PubMed ID: 28919551
[TBL] [Abstract][Full Text] [Related]
4. A novel design of a multi-antigenic, multistage and multi-epitope vaccine against Helicobacter pylori: An in silico approach.
Meza B; Ascencio F; Sierra-Beltrán AP; Torres J; Angulo C
Infect Genet Evol; 2017 Apr; 49():309-317. PubMed ID: 28185986
[TBL] [Abstract][Full Text] [Related]
5. Design of a new multi-epitope vaccine against
Chen Z; Zhu Y; Sha T; Li Z; Li Y; Zhang F; Ding J
Epidemiol Infect; 2021 May; 149():e136. PubMed ID: 34032200
[TBL] [Abstract][Full Text] [Related]
6. In silico analyses of heat shock protein 60 and calreticulin to designing a novel vaccine shifting immune response toward T helper 2 in atherosclerosis.
Karkhah A; Saadi M; Nouri HR
Comput Biol Chem; 2017 Apr; 67():244-254. PubMed ID: 28189968
[TBL] [Abstract][Full Text] [Related]
7. A novel multi-epitope peptide vaccine against cancer: an in silico approach.
Nezafat N; Ghasemi Y; Javadi G; Khoshnoud MJ; Omidinia E
J Theor Biol; 2014 May; 349():121-34. PubMed ID: 24512916
[TBL] [Abstract][Full Text] [Related]
8. A multi-epitope subunit vaccine based on CU/ZN-SOD, OMP31 and BP26 against Brucella melitensis infection in BALB/C mice.
Wang Y; Wu A; Xu Z; Zhang H; Li H; Fu S; Liu Y; Cui L; Miao Y; Wang Y; Zhumanov K; Xu Y; Sheng J; Yi J; Chen C
Int Immunopharmacol; 2024 Jan; 127():111351. PubMed ID: 38113688
[TBL] [Abstract][Full Text] [Related]
9. Vaccination with recombinant L7/L12-truncated Omp31 protein induces protection against Brucella infection in BALB/c mice.
Golshani M; Rafati S; Dashti A; Gholami E; Siadat SD; Oloomi M; Jafari A; Bouzari S
Mol Immunol; 2015 Jun; 65(2):287-92. PubMed ID: 25723468
[TBL] [Abstract][Full Text] [Related]
10. Development of an epitope-based vaccine inhibiting immune cells rolling and migration against atherosclerosis using in silico approaches.
Tourani M; Karkhah A; Najafi A
Comput Biol Chem; 2017 Oct; 70():156-163. PubMed ID: 28886485
[TBL] [Abstract][Full Text] [Related]
11. Development a multi-epitope driven subunit vaccine for immune response reinforcement against Serogroup B of Neisseria meningitidis using comprehensive immunoinformatics approaches.
Rostamtabar M; Rahmani A; Baee M; Karkhah A; Prajapati VK; Ebrahimpour S; Nouri HR
Infect Genet Evol; 2019 Nov; 75():103992. PubMed ID: 31394292
[TBL] [Abstract][Full Text] [Related]
12. Prediction of the Omp16 Epitopes for the Development of an Epitope-based Vaccine Against Brucellosis.
Rezaei M; Rabbani-Khorasgani M; Zarkesh-Esfahani SH; Emamzadeh R; Abtahi H
Infect Disord Drug Targets; 2019; 19(1):36-45. PubMed ID: 29984663
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of humoral and cellular immune responses to BP26 and OMP31 epitopes in the attenuated Brucella melitensis vaccinated sheep.
Wang W; Wu J; Qiao J; Weng Y; Zhang H; Liao Q; Qiu J; Chen C; Allain JP; Li C
Vaccine; 2014 Feb; 32(7):825-33. PubMed ID: 24370708
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of immune responses induced by polymeric OMP25-BLS Brucella antigen.
Yousefi S; Abbassi-Daloii T; Sekhavati MH; Tahmoorespur M
Microb Pathog; 2018 Feb; 115():50-56. PubMed ID: 29253594
[TBL] [Abstract][Full Text] [Related]
15. A multi-subunit based, thermodynamically stable model vaccine using combined immunoinformatics and protein structure based approach.
Rana A; Akhter Y
Immunobiology; 2016 Apr; 221(4):544-57. PubMed ID: 26707618
[TBL] [Abstract][Full Text] [Related]
16. A recombinant subunit vaccine based on the insertion of 27 amino acids from Omp31 to the N-terminus of BLS induced a similar degree of protection against B. ovis than Rev.1 vaccination.
Cassataro J; Pasquevich KA; Estein SM; Laplagne DA; Velikovsky CA; de la Barrera S; Bowden R; Fossati CA; Giambartolomei GH; Goldbaum FA
Vaccine; 2007 May; 25(22):4437-46. PubMed ID: 17442465
[TBL] [Abstract][Full Text] [Related]
17. Improved immunogenicity and protective efficacy of a divalent DNA vaccine encoding Brucella L7/L12-truncated Omp31 fusion protein by a DNA priming and protein boosting regimen.
Golshani M; Rafati S; Siadat SD; Nejati-Moheimani M; Shahcheraghi F; Arsang A; Bouzari S
Mol Immunol; 2015 Aug; 66(2):384-91. PubMed ID: 25968974
[TBL] [Abstract][Full Text] [Related]
18. Immunoinformatics prediction of OMP2b and BCSP31 for designing multi-epitope vaccine against Brucella.
Li Z; Zhang F; Zhang C; Wang C; Lu P; Zhao X; Hao L; Ding J
Mol Immunol; 2019 Oct; 114():651-660. PubMed ID: 31557626
[TBL] [Abstract][Full Text] [Related]
19. Multi-epitope DnaK peptide vaccine against S.Typhi: An in silico approach.
Verma S; Sugadev R; Kumar A; Chandna S; Ganju L; Bansal A
Vaccine; 2018 Jun; 36(28):4014-4022. PubMed ID: 29861180
[TBL] [Abstract][Full Text] [Related]
20. Escheriosome-mediated delivery of recombinant ribosomal L7/L12 protein confers protection against murine brucellosis.
Mallick AI; Singha H; Khan S; Anwar T; Ansari MA; Khalid R; Chaudhuri P; Owais M
Vaccine; 2007 Nov; 25(46):7873-84. PubMed ID: 17931756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
